title: Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy.
authors.affiliation: Institute of Biomedicine, Department of Anatomy, University of Turku, Finland.
authors.forename: Kaisa K
authors.initials: KK
authors.lastname: Ivaska
authors.forename: Kim
authors.initials: K
authors.lastname: Pettersson
authors.forename: Arja
authors.initials: A
authors.lastname: Nenonen
authors.forename: Kirsti
authors.initials: K
authors.lastname: Uusi-Rasi
authors.forename: Ari
authors.initials: A
authors.lastname: Heinonen
authors.forename: Pekka
authors.initials: P
authors.lastname: Kannus
authors.forename: H Kalervo
authors.initials: HK
authors.lastname: Väänänen
mesh_terms: D019386:Alendronate / Q000627:therapeutic use*; D015415:Biomarkers; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D007118:Immunoassay; D008875:Middle Aged; D015675:Osteocalcin / Q000652:urine*; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control / Q000652:urine; D013997:Time Factors
chemical_list: D015415:Biomarkers; D015675:Osteocalcin; D019386:Alendronate